DreamBrands New Formula Helps Men Feel Younger and Stronger While Naturally Raising Low-T Without Prescrip... ( PHOENIX Sept. 28 2011 /- DreamBrand...)

DreamBrands New Formula Helps Men Feel Younger and Stronger While Naturally Raising Low-T Without Prescription Drugs

Date:9/28/2011

PHOENIX, Sept. 28, 2011 /PRNewswire/ -- DreamBrands, internationally recognized for identifying healthy solutions that empower men and women to live fuller lives, presents Mdrive -- a natural supplement which includes an ingredient that clinical tests revealed promoted healthy free testosterone in an active group of subjects by 98%. Men who take Mdrive daily report increased strength, stamina, sex drive, muscle mass, recovery, respiration and focus.

Mdrive - A synergistic blend of powerful bio-active extracts from plants, roots, herbs and mushrooms - scientifically formulated to support the adrenal glands, raise free testosterone levels, and enrich nutritional blood supply to the body's organs and extremities - without costly hormones, dangerous steroids or addictive caffeine.

The Most Scientifically-Advanced Fuel Ever Formulated for a Man's Body

Mdrive creator, Gary Kehoe - DreamBrands CEO and product development expert - said this: "Men over 40 won't always talk to their physicians about personal issues such as Low-T. Even when ready to try to improve their overall well being and perhaps boost testosterone levels, they're hesitant about using prescription drugs. Though Mdrive is not a pharmaceutical treatment for low testosterone, we believe men will appreciate its natural formula."

Mdrive is formulated with Fenugreek Seed Extract which supports healthy testosterone levels without the need for costly hormone therapy; the Cordyceps Mushroom - which in human cardiovascular studies enhanced nutritional blood supply to the organs and extremities by supporting the ATP molecule which releases real energy; and the Maitake, Maca, American Ginseng and Damiana Extracts.

Mdrive is a daily supplement designed specifically for men who want to increase strength, stamina and overall vitality. Mdriv
'/>"/>

SOURCE DreamBrands
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. ISTA Pharmaceuticals Presents Results from Two Phase III Clinical Trials of Xibrom(TM) QD (Once-daily) Formulation at the American Academy of Ophthalmology Annual Meeting
2. New AVEENO(R) Eczema Care Product Line Offers Breakthrough Formulas to Help Manage the Signs and Symptoms of Eczema
3. Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure
4. Infant Formula Manufacturers Again under Ethical Cloud: Marketing Gimmick Linked to Serious Illnesses
5. Clinical Update - Decapeptyl(R)/Trelstar(R) 6-Month Formulation in Advanced Prostate Cancer
6. ISTA Pharmaceuticals Announces Results of Clinical Trial of Xibrom(TM) QD (Once-Daily) Formulation
7. Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations
8. NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation
9. New Data Highlight Positive Results of Namenda(R) (memantine HCl) Once-Daily Extended-Release Formulation
10. Spherics, Inc. Offers Extended Release Formulation for Sustained and Stable Levodopa Levels
11. Debiopharm Moves Towards a New 6-Month Formulation of Decapeptyl(R) to Further Help Prostate Cancer Patients

Post Your Comments:

(Date:5/23/2013)... 3SBio Inc. (NASDAQ: SSRX ... China -based biotechnology company focused on ... today that, at an extraordinary general meeting held ... favor of the proposal to authorize and approve ... dated February 8, 2013, among Decade Sunshine Limited, ...

(Date:5/23/2013)... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ) ... Life Science Firm of the Year by the Tech Council ... at the TCM,s 25 th Annual Tech Awards Celebration ... Awards Celebration recognizes the leaders and innovators in the technology ... and the surrounding regions. "We are deeply ...

(Date:5/23/2013)... de mayo de 2013 Volcano Corporation (NASDAQ: ... fabricante de herramientas de precisión para terapia guiadas ... la enfermedad vascular periférica y coronaria, anunció hoy ... enosine V asodilator I ndependent ... sesión de ensayo clínico hot line late breaking ...

Breaking Medicine Technology:3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 2 3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3 Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6

[0] 3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement [0] Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland [0] Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2

... Open enrollment is an opportune time to find the best ... 15 Through the end of the year, thousands of Nebraska ... This is when the state,s 268,000 Medicare beneficiaries get to ... in 2010. , Prescription drug coverage is a critical part ...

... , , NEW YORK, Dec. ... research report is available in its catalogue: , ... the U.S. and its International Trade [Q4 2009 ... just released December edition of Surgical and Medical ...

Cached Medicine Technology:Pharmacist Urges Nebraska Medicare Beneficiaries to Compare Prescription Plans 2 Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 2 Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 3 Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 4 Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 5 Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 6 Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 7 Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 8

Pharmacist Urges Nebraska Medicare Beneficiaries to Compare Prescription Plans Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition]

(Date:5/23/2013)... May 23, 2013 Da Vinci surgical ... a trial in Washington State May 23, according to ... in surgical robot lawsuits , expresses disappointment in ... Vinci lawsuits to not read a single verdict as ... (Estate of Fred E. Taylor v. Intuitive Surgical Inc.; ...

(Date:5/23/2013)... News) -- People who eat at fast-food restaurants are ... teens are the worst offenders, a new study found. ... meals by as much as 34 percent, parents of ... adults by as much as 20 percent," study lead ... from the Robert Wood Johnson Foundation, which helped fund ...

(Date:5/23/2013)... 2013 “Talk. They Hear You.” a ... parents to talk to children as young as nine ... launched today by the Substance Abuse and Mental Health ... conjunction with SAMHSA’s 2013 National Prevention Week—an annual health ... substance abuse and mental health issues. , SAMHSA’s latest ...

(Date:5/23/2013)... drug about to be tested in a clinical trial ... treatment for Alzheimer,s disease has failed to work with ... patients, according to results of a study by University ... of neuroscience affiliated with the Evelyn F. and William ... emphasized the importance of verifying promising research results before ...

(Date:5/23/2013)... New York, New York (PRWEB) May 23, 2013 ... products manufactured by C.R. Bard, Inc., continue to move ... District Court, Southern District of West Virginia, Bernstein Liebhard ... 17th, the Court denied a request by C.R. Bard ... claimed would reveal trade secrets and other confidential, proprietary ...

Breaking Medicine News(10 mins):Health News:Da Vinci Surgical Robot Lawsuit News: Rottenstein Law Group LLP Comments on Intuitive Win in Negligent Training Trial 2 Health News:How Many Calories in Your Fast-Food Meal? Guess Again 2 Health News:New Campaign to Help Parents Talk to Younger Children About the Dangers of Underage Drinking 2 Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 2 Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 3 Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 2 Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 3

[0] Da Vinci Surgical Robot Lawsuit News: Rottenstein Law Group LLP Comments on Intuitive Win in Negligent Training Trial [0] How Many Calories in Your Fast-Food Meal? Guess Again [0] New Campaign to Help Parents Talk to Younger Children About the Dangers of Underage Drinking [0] Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study [0] Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits

... Universal Health Services, Inc. (NYSE: UHS ) ... pay a cash dividend of $0.08 per share on ... June 1, 2009.Universal Health Services, Inc. is one of ... acute care and behavioral health hospitals, and ambulatory centers ...

... New grants will serve communities in outstate Minnesota ... of Directors approved four regional grants dedicated to ... and policy advocacy. The grants will provide resources ... new grant awards show our continuing commitment to ...

... Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical ... million in a second Series A financing extension ... was again led by Vivo Ventures. This capital ... development activities and strategic business objectives."Sagent,s business model ...

... The American Association for Homecare supports expanded anti-fraud efforts ... and the Department of Health and Human Services (HHS) ... two agencies outlined plans for expanding anti-fraud strike forces ... Care Fraud Prevention and Enforcement Action Team. Even ...

... dialysis patients, quality of life, study says , , WEDNESDAY, ... and the anti-clotting drug dipyridamole reduces blockages and extends ... for kidney dialysis, new research has found. , When ... stenosis -- a narrowing of blood vessels -- at ...

... to flu variant that circulated before 1957 , , WEDNESDAY, May ... immunity to the new H1N1 swine flu virus because of ... 1957, a U.S. infectious-disease expert said Wednesday. , "The further ... to have been exposed to H1N1 virus back before 1957, ...

Universal Health Services, Inc. Announces Dividend ClearWay Minnesota(SM) Board Approves Four Regional Grants Sagent Pharmaceuticals Announces Extension of Series A Financing American Association for Homecare Supports Expanded Federal Efforts by DOJ and HHS to Combat Medicare Fraud Drug Combo Keeps Kidney Artery-Vein Grafts Viable Older Adults May Have Some Immunity to Swine Flu

... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...

... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

Medicine Products:

Allergen, Tree,Baccharus Spp/Groundsel Tree Allergen, Parasite, Ascaris Allergen, Occupational, Phthalic Anhydride Allergen, Occupational, Formaldehyde